Skip to main content
Erschienen in: Breast Cancer Research 1/2000

01.03.2000 | Meeting abstract

Mammary epithelial cells immortalized by over-expression of the catalytic subunit of human telomerase may represent a model for mammary epithelial differentiation

verfasst von: J DiRenzo, R Rivera-Gonzalez, M Brown

Erschienen in: Breast Cancer Research | Sonderheft 1/2000

Einloggen, um Zugang zu erhalten

Excerpt

Retroviral transfer of a cDNA encoding human Telomeric End Reverse Transcriptase (hTERT) into primary human mammary epithelia has led to the establishment of several clonally derived lines of Immortalized Mammary Epithelial Cells (IMECs). Unlike their empty vector control counterparts, the IMECs were capable of bypassing replicative senescence. In doing so, they exhibited a marked decrease in the protein levels of the retinoblastoma gene product, Rb, and a complete loss of the cyclin-dependent kinase inhibitor p16, events which are hallmarks of the immortalization process. In culture, IMECs proliferate in a manner that is dependent on insulin and Epidermal Growth Factor (EGF). Interestingly, these IMECs can be induced to undergo a differentiation which is characterized by an arrest of the cell cycle in G1 and the loss of cyclin D1 expression. During this differentiation process, IMECs establish cell-cell interactions that lead to an ordered arrangement of cells in two dimensions. Further genetic and biochemical characterization may hopefully reveal the nature of these differentiated IMECs. …
Metadaten
Titel
Mammary epithelial cells immortalized by over-expression of the catalytic subunit of human telomerase may represent a model for mammary epithelial differentiation
verfasst von
J DiRenzo
R Rivera-Gonzalez
M Brown
Publikationsdatum
01.03.2000
Verlag
BioMed Central
Erschienen in
Breast Cancer Research / Ausgabe Sonderheft 1/2000
Elektronische ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr121

Weitere Artikel der Sonderheft 1/2000

Breast Cancer Research 1/2000 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.